Brief: Biocartis Starts Scrips Sale Through Private Placement

Biocartis NV

29/11/2022 09:58

Nov 29 (Reuters) - BIOCARTIS GROUP NV  BCART.BR :
    * ANNOUNCES 55.91% OFOFFEREDSHARES SUBSCRIBED AT CLOSING OF
RIGHTS
SUBSCRIPTION PERIOD FOR HOLDERS OF PREFERENTIAL RIGHTS, AND
START OF THESALE OF SCRIPS THROUGH A PRIVATE PLACEMENT TO
INSTITUTIONAL INVESTORS
    * ANNOUNCES THAT 18,718,468 NEW SHARES OR 55.91% OF MAXIMUM
33,476,932 NEW SHARES IT OFFERED AS PART OF A PUBLIC OFFERING TO
EXISTING SHAREHOLDERS OF COMPANY AND ANY HOLDERS OF AN
EXTRA-LEGAL PREFERENTIAL RIGHT
    * 25,827,312 PREFERENTIAL RIGHTS, REPRESENTED BY COUPON N°1,
THAT
HAVE NOT BEEN EXERCISED DURING OR AT END OF RIGHTS SUBSCRIPTION
PERIOD WERE CONVERTED INTO AN EQUAL NUMBER OF SCRIPS
    * THESE SCRIPS WILL BE OFFERED FOR SALE THROUGH A PRIVATE
PLACEMENT TO INSTITUTIONAL INVESTORS
    * THIS SALE THROUGH SCRIPS PRIVATE PLACEMENT WILL START
TODAY AND
IS EXPECTED TO END TODAY
    * PURCHASERS OF SCRIPS IN SCRIPS PRIVATE PLACEMENT MUST
IRREVOCABLY UNDERTAKE TO SUBSCRIBE FOR CORRESPONDING NUMBER OF
OFFERED SHARES IN COMPANY AT EUR 0.75 PER OFFERED SHARE AT RATIO
OF 4 OFFERED SHARES PER 7 PREFERENTIAL RIGHTS UNDER FORM OF
SCRIPS
    * PAYMENT OF SUBSCRIPTIONS IN SCRIPS PRIVATE PLACEMENT IS
EXPECTED
TO TAKE PLACE ON OR AROUND 2 DECEMBER 2022 AND WILL BE MADE BY
DELIVERY AGAINST PAYMENT
    * DELIVERY OF OFFERED SHARES WILL TAKE PLACE ON OR AROUND 2
DECEMBER 2022
    * OFFERED SHARES ARE EXPECTED TO BECOME TRADEABLE ON
REGULATED
MARKET OF EURONEXT BRUSSELS ON 2 DECEMBER 2022

Source text for Eikon:  ID:nGNE2XfK27 
Further company coverage:  BCART.BR 
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))